Drug Associated Toxic Nephropathy Identified in the United States Food and Drug Administration Adverse Event Reporting System Database

被引:0
|
作者
Balaha, Mohamed F. [1 ]
Ahmed, Nehad J. [1 ]
Khafagy, El Sayed A. [2 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Dept Clin Pharm, Coll Pharm, Alkharj, Saudi Arabia
[2] Prince Sattam Bin Abdulaziz Univ, Dept Pharmaceut, Coll Pharm, Alkharj, Saudi Arabia
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2022年 / 41卷 / 11期
关键词
adverse event; nephrotoxic drug; nephrotoxicity; reporting; ACUTE-RENAL-FAILURE; NEPHROTOXICITY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acute kidney injury has a complex pathophysiology, but the main causes are sepsis, ischemia, and nephrotoxicity. Drugs cause about 20% of nephrotoxicity. The aim of this study was to describe reports of drug-associated toxic nephropathy. The FDA Adverse Event Reporting System was used to conduct a retrospective, descriptive analysis of all reported drug-associated nephrotoxicity. A total of 7924 reports of drug-associated toxic nephropathy were submitted to the FDA Adverse Event Reporting System. The most reported medications that were associated with toxic nephropathy were tacrolimus (11.21%), cyclosporine (11.13%), vancomycin (9.58%), cisplatin (6.51%), methotrexate (5.04%), mycophenolate mofetil (4.85%), cyclophosphamide (4.76%), prednisone (3.92%), etoposide (3.79%), and tenofovir disoproxil fumarate (3.15%). Immunosuppressive drugs, antibacterial agents, antineoplastic therapies, and antiviral drugs are among the most regularly used medications that have been recognized as potentially nephrotoxic. Early detection can be achieved through careful observation and monitoring of renal function, while fast discontinuation of toxic medical treatment is necessary to prevent additional damage and, in many cases, entirely reverse renal injury.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database
    Welch, Hanna K.
    Kellum, John A.
    Kane-Gill, Sandra L.
    PHARMACOTHERAPY, 2018, 38 (08): : 785 - 793
  • [2] Drug-associated congenital anomalies of the external ear identified in the United States food and drug administration adverse event reporting system database
    Li, Xinyu
    Hao, Jiajia
    Li, Datao
    Zhang, Ruhong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
    Toki T.
    Ono S.
    Drugs - Real World Outcomes, 2018, 5 (2) : 117 - 128
  • [4] Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database
    Ashwin Kamath
    Sahana D. Acharya
    Rashmi R. Rao
    Sheetal D. Ullal
    Scientific Reports, 11
  • [5] Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database
    Kamath, Ashwin
    Acharya, Sahana D.
    Rao, Rashmi R.
    Ullal, Sheetal D.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study
    Wu, Jingying
    Wu, Jianru
    Tang, Biyu
    Wang, Xinru
    Wei, Fenfang
    Zhang, Yi
    Li, Limin
    Li, Hongqiao
    Wang, Bei
    Wu, Wenyu
    Hong, Xiang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Adverse drug events of denosumab: Data-mining based on the United States Food and Drug Administration Adverse Event Reporting System database
    Liu, Shaohua
    Jiang, Wangyan
    Guo, Jieru
    Zhou, Xinrong
    Liu, Zhelong
    JOURNAL OF RESEARCH IN PHARMACY, 2024, 28 (04): : 1220 - 1230
  • [8] Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database
    Zheng, Yi
    Guo, Xiaojing
    Chen, Chenxin
    Chi, Lijie
    Guo, Zhijian
    Liang, Jizhou
    Wei, Lianhui
    Chen, Xiao
    Ye, Xiaofei
    He, Jia
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (02) : 865 - 873
  • [9] Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database
    Zheng, Yi
    Guo, Xiaojing
    Chen, Chenxin
    Chi, Lijie
    Guo, Zhijian
    Liang, Jizhou
    Wei, Lianhui
    Chen, Xiao
    Ye, Xiaofei
    He, Jia
    PHARMACEUTICALS, 2023, 16 (01)
  • [10] Enoxaparin Associated Hepatic Events: a Review of the United States Food and Drug Administration Adverse Event Reporting System (FAERS)
    Hahn, Katherine
    Lewis, James H.
    GASTROENTEROLOGY, 2015, 148 (04) : S1081 - S1082